Availability and Functionality of Infection Prevention and Control Systems in Health Facilities Providing TB and COVID-19 Services in Plateau State, Nigeria
Abstract:
Nigeria continues to face the challenge of emerging and resurgence infectious diseases, including tuberculosis (TB) and coronavirus disease 2019 (COVID-19). Healthcare facilities can inadvertently facilitate transmission of these pathogens due to frequent interactions among patients, visitors, and healthcare workers. Strengthening infection prevention and control (IPC) systems is therefore essential to improve health system resilience and advance progress toward universal health coverage. This cross-sectional facility-based study assessed the status of IPC programmes using the World Health Organization Infection Prevention and Control Assessment Framework (IPCAF). Trained field staff administered the IPCAF tool across selected health facilities to evaluate performance across the core components of IPC programmes. Data collected from each facility were compiled in Microsoft Excel and analyzed using IBM SPSS version 25. We assessed a total of thirty health facilities. Overall IPC performance was predominantly at the basic level, with an average score of 41.5%. Some facilities demonstrated intermediate capacity in specific areas such as staffing and infrastructure; however, none achieved an advanced level of IPC performance. These findings highlight significant gaps in IPC implementation across the assessed facilities. Strengthening IPC policies, systems, and institutional capacity is therefore critical. National disease control programmes should prioritize targeted interventions to improve and sustain IPC practices across healthcare facilities in order to reduce the risk of healthcare-associated transmission of infectious diseases.References:
[1].
Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF,
Watson OJ, Whittaker C, Hamlet A, Smith JA, Winskill P, Verity R, et al.
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in
low-income and middle-income countries: a modelling study. Lancet Global
Health. 2020;July 13. https://doi.org/10.1016/S2214-109X(20)30288-6
[2].
Fauci AS. Robert H. Ebert Memorial Lecture - Emerging
and Re-emerging Infectious Diseases: The Perpetual Challenge. Milbank Memorial
Fund. 2005. https://www.milbank.org/wp-content/uploads/2016/04/0601Fauci.pdf
[3].
Cioboata R, Biciusca V, Olteanu M, Vasile CM. COVID-19
and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective.
Journal of Clinical Medicine. 2023;12:4784.
[4].
Visca D, Ong CWM, Tiberi S, Centis R, D’Ambrosio L,
Chen B, Mueller J, Mueller P, Duarte R, Dalcolmo M, Sotgiu G, Migliori GB,
Goletti D. Tuberculosis and COVID-19 interaction: A review of biological,
clinical, and public health effects. Pulmonology. 2021;27(2):151-165. https://doi.org/10.1016/j.pulmoe.2020.12.012
[5].
Morens DM, Folkers GK, Fauci AS. The challenge of
emerging and re-emerging infectious diseases. Nature. 2004;430. https://www.nature.com/nature
[6].
Department of Health. UK Five Year Antimicrobial
Resistance Strategy 2013 to 2018. 2013.
[7].
Deryabina A, Lyman M, Yee D, Gelieshvilli M, et al.
Core components of infection prevention and control programs at the facility
level in Georgia: Key challenges and opportunities. Antimicrobial Resistance
and Infection Control. 2021;10:39. https://doi.org/10.1186/s13756-020-00879-3
[8].
Larson E. A retrospective on infection control. Part
1: Nineteenth century - Consumed by fire. American Journal of Infection
Control. 1997;25:236-241.
[9].
Bolyard EA, Tablan OC, Williams WW, Pearson ML,
Shapiro CN, Deitchman SD, The Hospital Infection Control Practices Advisory
Committee. Guideline for infection control in health care personnel, 1998.
American Journal of Infection Control. 1998;26:289-354.
[10]. Sirleaf E, Clark H. COVID-19: Make it the Last Pandemic. Report of the
Independent Panel for Pandemic Preparedness and Response. 2021.
[11]. Espinal MA. The global situation of MDR-TB. Tuberculosis. 2003;83:44-51.
http://dx.doi.org/10.1016/S1472-9792(02)00058-6
[12]. Falzon D, et al. The impact of the COVID-19 pandemic on the global
tuberculosis epidemic. Frontiers in Immunology. 2023. https://doi.org/10.3389/fimmu.2023.1234785
[13]. Alhamlan FS, Al-Qahtani A. SARS-CoV-2 Variants: Genetic Insights,
Epidemiological Tracking, and Implications for Vaccine Strategies.
International Journal of Molecular Sciences. 2025;26:1263.
[14]. Federal Ministry of Health - Nigeria Centre for Disease Prevention and
Control. The Nigerian Manual of Infection Prevention and Control. Federal
Ministry of Health. 2021.
[15]. Fofanah BD, Abrahamyan A, Maruta A, Kallon C, Thekkur P, Kamara IF,
Njuguna CK, Squire JS, Kanu JS, Bah AJ, et al. Achieving Minimum Standards for
Infection Prevention and Control in Sierra Leone: Urgent Need for a Quantum
Leap in Progress in the COVID-19 Era! International Journal of Environmental
Research and Public Health. 2022;19:5642. https://doi.org/10.3390/ijerph19095642
[16]. Kim GU, Kim MJ, Ra SH, Lee J, Bae S, Jung J, Kim S-H. Clinical
characteristics of asymptomatic and symptomatic patients with mild COVID-19.
Clinical Microbiology and Infection. 2020;26:948.e1-948.e3.
[17]. Houben RMGJ, Dodd PJ. The Global Burden of Latent Tuberculosis
Infection: A Re-estimation Using Mathematical Modelling. PLoS Medicine.
2016;13(10). https://doi.org/10.1371/journal.pmed.1002152
[18]. Houghton C, Meskell P, Delaney H, Smalle M, Glenton C, Booth A, Chan
XHS, Devane D, Biesty LM. Barriers and facilitators to healthcare workers’
adherence with infection prevention and control (IPC) guidelines for
respiratory infectious diseases: A rapid qualitative evidence synthesis.
Cochrane Database of Systematic Reviews. 2020;4, 1-55.
[19]. Ige FA, Ohihoin AG, Amuda BO, Amoo OS, Onwuamah CK, Okwuraiwe AP, Shaibu
JO, Odewale EO, James AB, Kayode A, Adeshina A, Audu RA. The Effectiveness of
Infection Control Practices among Health Care Workers Responding to the
COVID-19 Pandemic in Nigeria. Advances in Infectious Diseases. 2021;11:232-239.
https://doi.org/10.4236/aid.2021.112021
[20]. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak
P. Global trends in emerging infectious diseases. Nature. 2008;451. https://doi.org/10.1038/nature06536
[21]. Raviglione M, Sulis G. Tuberculosis 2015: Burden, Challenges and
Strategy for Control and Elimination. Infectious Disease Reports. 2016;8:6570. https://doi.org/10.4081/idr.2016.6570
[22]. Tomczyk S, Twyman A, de Kraker MEA, Rehse APC, Tartari E, Toledo JP,
Cassini A, Pittet D, Allegranzi B. The first WHO global survey on infection
prevention and control in health-care facilities. The Lancet Infectious
Diseases. 2022. https://doi.org/10.1016/S1473-3099(21)00809-4
[23]. Ogiri SO. A Rapid Appraisal of Infection Prevention and Control
Programmes in Health Facilities Implementing Tuberculosis and Coronavirus
Disease-19 Services in Plateau State, Nigeria. Dissertation submitted to Texila
American University in partial fulfillment of the requirements for the award of
the Degree of Doctor of Philosophy in Public Health. 2026.
[24]. World Health Organization. IHR Core Capacity Monitoring Framework:
Checklist and Indicators for Monitoring Progress in the Development of IHR Core
Capacities in States Parties. WHO/HSE/GCR/2013.2. 2013.
[25]. World Health Organization. Improving Infection Prevention and Control at
the Health Facility: Interim Practical Manual for Supporting Implementation of
the WHO Infection Prevention and Control Programmes. 2018.
[26]. World Health Organization. Guideline on Infection Prevention and Control
of Epidemic- and Pandemic-Prone Acute Respiratory Infections in Health Care.
2014.
[27]. World Health Organization. Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Facility Level. 2016.
